Symposium for Rheumatologists, Immunologists and Pediatricians (in French):
Maladies fébriles récurrentes et syndromes auto-inflammatoires :
Diagnostic et traitement de l’enfant à l’adulte
Young Investigators Meeting Opening Ceremony: Jurg Tschopp Memorial Lecture:
What’s new in auto-inflammation since 2010? : Michael McDermott,
Tribute to Jurg Tschopp: Fabio Martinon, Epalinges, Switzerland
Welcome Reception Joost Frenkel: News on the treatment of HIDS
François Spertini: Adverse events and allergic responses to
Session 1: CAPS and inflammasome
Update on IL-1 dysregulation, Charles Dinarello, Denver, USA
NLRs, Basic mechanism of action and relevance in diseases: Jenny
Mutation negative CAPS: Joost Frenkel, Utrecht, Netherlands
Coffee break Session 2: FMF
SAA, amyloidosis and cell damage: Bouke Hazenberg, Groningen,
FMF heterozygotes: Véronique Hentgen, Versailles, France
Treatment of FMF in 2013: Seza Ozen, Ankara, Turkey
Session 3: Granulomatous diseases
Physiopathology of granuloma: Frédéric Altare, Nantes, France
Immunodeficiency and Granulomatosis: Alexandre Belot, Lyon,
Auto-inflammatory granulomatous diseases: Carine Wouters,
Workshops
1. Genetic: Taxonomy of hereditary auto-inflammatory diseases:
Eldad Ben Chetrit, Jerusalem, Israel
2. Biomarkers (S100A proteins, cytokines, CRP-SAA)
Dirk Holzinger, Münster, Germany
3. Patient oriented research techniques in the auto-inflammatory
Coffee break Session 4: Monogenic autoinflammatory diseases
ER and stress: Fabio Martinon, Epalinges, Switzerland
Immunoproteosome: Ivona Aksentijevitch, Bethesda, USA
New monogenic auto-inflammatory periodic syndromes: Marco PRO-CON: Controversies on the mode of inheritance of AIDs Isabelle Touitou, Montpellier, France and Michael Morris, Geneva,
Jasmine Kummerle-Deschner: Practical diagnostic aspects of CAPS
Anna Simon: Triggering causes for AID and attack prevention
Seza Ozen: Practical aspects of FMF treatment
Hans Acha-Orbea: Inflammasome activation in different diseases
Session 5: Non-monogenic AIDs
Genome wide association studies in polygenic AIDs: Dan Kastner,
Chronic recurrent multifocal osteomyelitis: Hermann Girschick,
PFAPA Syndrome: Michaël Hofer, Lausanne, Switzerland
Coffee break Session 6+7: Abstract presentations Coffee break Session 8: Systemic-onset JIA and AOSD
Update on the pathophysiology of So-JIA and AOSD: Virginia
Update on the treatment of So-JIA in 2013: Rolando Cimaz,
PRO-CON: Prednisone versus Biotherapy in early treatment of So- Alberto Martini, Genoa, Italy / Nico Wullfraat, Utrecht, Netherland
Jasmine Kummerle-Deschner: Long-term CAPS treatment by anti-
Anna Simon: How to do research on diseases with intermittent
Rolando Cimaz: Practical aspects of biotherapies in SOJIA
Mike Morris: Guidelines for genetic diagnosis of hereditary fevers
Alexander So: Microcristals and inflammation
Session 9: Behçet
Pathogenesis of Behcet's disease: HLA and beyond: Ahmed Gül,
Treatment of Behçet’s uveitis: Yan Guex-Crosier, Lausanne,
Behçet registry, PED-BD: Isabelle Kone-Paut, Kremlin-Bicêtre,
Coffee break Session 10+11: Abstract presentations Session 12: New developments in auto-inflammation: new diseases and therapeutic targets
Diabetes and auto-inflammation, Mark Donath, Zurich Switzerland
Auto-inflammation in the skin, psoriasis: Michel Gilliet, Lausanne,
New targets for the treatment of auto-inflammatory diseases:
Coffee break Session 13: Late breaking abstracts Congress dinner Session 14: New developments in auto-inflammation: from regulation to biotherapies
Regulatory cytokines and cells dampening (auto-) inflammation:
Side effects of biotherapies, novel aspects: David Isenberg, London,
Coffee break Session 15: Difficult case presentations
BIOGRAPHICAL SKETCH Provide the following information for the key personnel and other significant contributors. Follow this format for each person. DO NOT EXCEED FOUR PAGES. EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such University of Western Ontario, London ON A. Positions and Honors. Positions and Employment 1989-1991 Head, Cli
HARDWARE DATA AND PROGRAM REPRESENTATION Chapter Objective 1: Most digital computers work in a two-state, or binary , fashion. It is convenient to think ofthese binary states in terms of 0s and 1s. Computer people refer to these 0s and 1s as bits . Converting data to these 0s and 1s is called digital data representation . While most individuals use the decimal number system to